Micromachines,
Год журнала:
2024,
Номер
15(9), С. 1103 - 1103
Опубликована: Авг. 30, 2024
Rapid
prototyping
has
produced
accessible
manufacturing
methods
that
offer
faster
and
more
cost-effective
ways
to
develop
microscale
systems
for
cellular
testing.
Commercial
3D
printers
are
now
increasingly
adapted
soft
lithography,
where
elastomers
used
in
tandem
with
3D-printed
substrates
produce
vitro
cell
assays.
Newfound
abilities
prototype
have
begun
expand
fundamental
bioengineering
research
the
visual
system
complement
tissue
engineering
studies
reliant
upon
complex
microtechnology.
This
project
printing
elastomeric
devices
examined
responses
of
retinal
cells
flow.
Our
experiments
fabricated
molds
using
metal
milling,
resin
stereolithography,
fused
deposition
modeling
via
plastic
printing.
The
were
connected
flow
pumps
simulate
different
conditions
phenotypic
endothelial
neural
significant
neurovascular
barriers
retina.
results
indicated
microdevices
demonstrated
differences
survival
morphology
response
external
barrier
function.
Modern
technology
shows
great
potential
rapid
production
testing
will
contribute
both
our
understanding
development
new
therapies.
Future
incorporate
varied
stimuli
as
well
extracellular
matrices
expanded
subsets
cells.
Micromachines,
Год журнала:
2024,
Номер
15(9), С. 1137 - 1137
Опубликована: Сен. 6, 2024
This
review
explores
significant
advancements
in
polymer
science
and
fabrication
processes
that
have
enhanced
the
performance
broadened
application
scope
of
microfluidic
devices.
Microfluidics,
essential
biotechnology,
medicine,
chemical
engineering,
relies
on
precise
fluid
manipulation
micrometer-sized
channels.
Recent
innovations
materials,
such
as
flexible,
biocompatible,
structurally
robust
polymers,
been
pivotal
developing
advanced
systems.
Techniques
like
replica
molding,
microcontact
printing,
solvent-assisted
injection
3D
printing
are
examined,
highlighting
their
advantages
recent
developments.
Additionally,
discusses
diverse
applications
polymer-based
devices
biomedical
diagnostics,
drug
delivery,
organ-on-chip
models,
environmental
monitoring,
industrial
processes.
paper
also
addresses
future
challenges,
including
enhancing
resistance,
achieving
multifunctionality,
ensuring
biocompatibility,
scaling
up
production.
By
overcoming
these
potential
for
widespread
adoption
impactful
use
technologies
can
be
realized.
Nanomaterials,
Год журнала:
2025,
Номер
15(2), С. 104 - 104
Опубликована: Янв. 10, 2025
Microfluidic
sensors
incorporated
onto
chips
allow
sensor
miniaturization
and
high-throughput
analyses
for
point-of-care
or
non-clinical
analytical
tools.
Three-dimensional
(3D)
printing
based
on
femtosecond
laser
direct
writing
(fs-LDW)
is
useful
creating
3D
microstructures
with
high
spatial
resolution
because
the
structures
are
printed
in
space
along
a
designated
light
path.
High-performance
biochips
can
be
fabricated
using
‘ship-in-a-bottle’
integration
technique,
which
functional
microcomponents
biomimetic
embedded
inside
closed
microchannels
fs-LDW.
Solutions
containing
protein
biomacromolecules
as
precursor
used
to
fabricate
that
retain
their
native
functions.
Here,
we
demonstrate
ship-in-a-bottle
of
pure
proteinaceous
exhibit
pH
sensitivity.
We
mesh
gap
sizes
10
5
μm.
The
these
gaps
changed
when
exposed
physiological
buffers
ranging
from
4
10.
size
shrunk
expanded
repeatedly
by
changing
surrounding
buffer.
Fs-LDW
enables
construction
microscopic
meshes
dynamic
functions
such
sensing
might
find
applications
filtering
particles
microfluidic
channels.
ACS Applied Materials & Interfaces,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 13, 2025
Compared
to
cultured
2D
cell
monolayers,
3D
multicellular
spheroids
are
more
realistic
tumor
models.
Nonetheless,
remain
under-utilized
in
preclinical
research,
part,
because
there
is
a
lack
of
fluorescence
sensors
that
can
noninvasively
interrogate
all
the
individual
cells
within
spheroid.
This
present
study
describes
deep-red
fluorogenic
molecular
probe
for
microscopic
imaging
contain
high
level
nitroreductase
enzyme
activity
as
biomarker
hypoxia.
A
first-generation
version
produced
"turn-on"
monolayer
under
hypoxic
conditions;
however,
it
was
not
useful
spheroid
only
accumulated
peripheral
cells.
To
guide
structural
optimization
process,
an
intuitive
theoretical
membrane
partition
model
conceived
predict
how
dosed
will
distribute
The
identifies
three
limiting
diffusion
pathways
determined
by
probe's
properties.
lipophilic
with
affinity
rapidly
becomes
trapped
membranes
In
contrast,
very
hydrophilic
molecule
negligible
diffuses
through
intercellular
space
and
rarely
enters
However,
intermediate
undergoes
sequential
out
distributes
Using
predictive
tool,
second-generation
fluorescent
prepared
smaller
structure,
optical
sectioning
using
structured
illumination
or
light
sheet
microscopy
revealed
roughly
even
throughout
permeation
likely
be
broadly
applicable
various
classes
molecules
nanoparticles
enable
distribution
Journal of Translational Medicine,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 28, 2025
The
intimate
correlation
between
cardiovascular
diseases
and
other
organ
pathologies,
such
as
metabolic
kidney
diseases,
underscores
the
intricate
interactions
among
these
organs.
Understanding
inter-organ
communications
is
crucial
for
developing
more
precise
drugs
effective
treatments
systemic
diseases.
While
animal
models
have
traditionally
been
pivotal
in
studying
interactions,
human-induced
pluripotent
stem
cells
(hiPSCs)
offer
distinct
advantages
when
constructing
vitro
models.
Beyond
conventional
two-dimensional
co-culture
model,
hiPSC-derived
humanoid
organoids
emerged
a
substantial
advancement,
capable
of
replicating
essential
structural
functional
attributes
internal
organs
vitro.
This
breakthrough
has
spurred
development
multilineage
organoids,
assembloids,
organoids-on-a-chip
technologies,
which
allow
enhanced
physiological
relevance.
These
technologies
shown
great
potential
mimicking
coordinated
organogenesis,
exploring
disease
pathogenesis,
facilitating
drug
discovery.
As
central
system,
heart
serves
focal
point
an
extensively
studied
network
interactions.
review
focuses
on
advancements
challenges
organs,
presenting
comprehensive
exploration
this
cutting-edge
approach
research.
Drug Discovery Today,
Год журнала:
2025,
Номер
unknown, С. 104360 - 104360
Опубликована: Апрель 1, 2025
Artificial
intelligence
(AI)
is
reshaping
preclinical
drug
research
offering
innovative
alternatives
to
traditional
animal
testing.
Advanced
techniques,
including
machine
learning
(ML),
deep
(DL),
AI-powered
digital
twins
(DTs),
and
AI-enhanced
organ-on-a-chip
(OoC)
platforms,
enable
precise
simulations
of
complex
biological
systems.
AI
plays
a
critical
role
in
overcoming
the
limitations
DTs
OoC,
improving
their
predictive
power
scalability.
These
technologies
facilitate
early-stage,
reliable
evaluations
safety
efficacy,
addressing
ethical
concerns,
reducing
costs,
accelerating
development
while
adhering
3Rs
principle
(Replace,
Reduce,
Refine).
By
integrating
with
these
advanced
models,
can
achieve
greater
accuracy
efficiency
discovery.
This
review
examines
transformative
impact
research,
highlighting
its
advancements,
challenges,
steps
needed
establish
as
cornerstone
efficient
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 28, 2025
Abstract
Endometriosis
(EMs),
a
significant
global
health
issue,
characterized
by
unclear
pathogenesis,
nonspecific
symptoms,
and
poor
treatment
outcomes.
The
organ‐on‐chip
technology
has
achieved
great
advances
in
disease
modeling,
yet
its
potential
EMs‐related
research
remains
largely
untapped.
Herein,
microfluidic
chip
platform
that
integrates
primary
cell‐laden
microcapsules
for
personalized
drug
evaluation.
Specifically,
human
ectopic
endometrial
stromal
cells
(hESCs)
within
featuring
biocompatible
carboxymethyl
cellulose
(CMC)
core
stable
alginate
(ALG)
shell
using
precise
electrospray
are
encapsulated.
These
integrated
into
with
branched
gradient
generator
multiple
cell‐culture
chambers,
enabling
tailored
high‐throughput
screening.
By
exposing
hESCs‐microcapsules
derived
from
of
distinct
patient
individuals
to
various
drugs
on‐chip,
inter‐individual
variability
was
revealed,
strong
correlation
clinical
This
unique
combination
patient‐specific
3D
microenvironments
dynamic
control
represents
paradigm
shift
EMs
research.
Further
integrating
omics
techniques,
capability
exploring
promising
is
showcased.
results
reveal
the
could
deliver
dependable
screening
outcomes,
thereby
benefiting
both
scientific
inquiries
therapies.
Polymers,
Год журнала:
2025,
Номер
17(9), С. 1263 - 1263
Опубликована: Май 6, 2025
For
organ-on-a-chip
(OoC)
engineering,
the
use
of
biocompatible
coatings
and
materials
is
not
only
recommended
but
essential.
Extracellular
matrix
(ECM)
components
are
commonly
used
as
due
to
their
effects
on
cell
orientation,
protein
expression,
differentiation,
adhesion.
Among
most
frequently
collagen,
fibronectin,
Matrigel,
according
specific
type
intended
OoC
application.
Additionally,
such
polydimethylsiloxane
(PDMS),
thermoplastics,
chitosan,
alginate
serve
scaffolding
biomechanical
properties
biocompatibility.
Here,
we
discuss
some
employed
coating
techniques,
including
SAMs,
dip
coating,
spin
microcontact
printing,
3D
bioprinting,
each
offering
advantages
drawbacks.
Current
challenges
comprise
enhancing
biocompatibility,
exploring
novel
materials,
improving
scalability
reproducibility.